NKGNW
NKGen Biotech, Inc. Warrants
NASDAQ · Healthcare · Biotechnology · US
$0.03
+2408.33%0
Insider buys (3m)
0
Insider sells (3m)
$0.00
Net value (3m)
—
Price return (3m)
Form 4 filings
| Date | Insider | Activity | Shares | Price |
|---|---|---|---|---|
| Jun 2, 2025 | CFIC-2015 NV Family Investments, LLC · 10 percent owner | Purchase | 39,339,103 | $0.13 |
| Jun 2, 2025 | CFIC-2015 NV Family Investments, LLC · 10 percent owner | Purchase | 19,669,552 | $0.13 |
| May 7, 2025 | Song Paul Y. · officer: Chief Executive Officer | Purchase | 41,699,449 | $0.13 |
| May 7, 2025 | Song Paul Y. · officer: Chief Executive Officer | Purchase | 20,849,725 | $0.13 |
| Dec 10, 2024 | Scott Kathleen D. · director | A-Award | 500,000 | $0.44 |
| Dec 10, 2024 | Scott Kathleen D. · director | A-Award | 300,000 | $1.62 |
| Dec 10, 2024 | Klowden Michael · director | A-Award | 500,000 | $0.44 |
| Dec 10, 2024 | Klowden Michael · director | A-Award | 300,000 | $1.62 |
| Dec 10, 2024 | Song Paul Y. · officer: Chief Executive Officer | A-Award | 2,000,000 | $0.44 |
| Dec 10, 2024 | Graf James A · officer: Chief Financial Officer | A-Award | 500,000 | $0.44 |
| Jul 18, 2024 | Gottardis Marco · director | A-Award | 300,000 | $2.00 |
| Feb 14, 2024 | Scott Kathleen D. · director | A-Award | 300,000 | $1.62 |
| Feb 14, 2024 | Kim Yong Man · officer: CSO and CIO | A-Award | 75,000 | $1.62 |
| Feb 14, 2024 | Song Paul Y. · director, officer: Chief Executive Officer | A-Award | 1,260,000 | $1.62 |
| Feb 14, 2024 | Gagnon Pierre · officer: Chief Operating Officer | A-Award | 360,000 | $1.62 |
| Feb 14, 2024 | Klowden Michael · director | A-Award | 300,000 | $1.62 |
Insider activity from SEC Form 4; institutional positioning from 13F filings · Latest filing Jun 2, 2025